Financial Performance - Q3 Fiscal 2025 - Net sales reached $380.3 million, a 6.6% year-over-year increase, driven by higher volumes and pricing across most product lines[12, 25, 30] - Gross margin increased by 150 bps year-over-year to 38.3%, driven by manufacturing efficiencies and increased volumes[12, 26, 27] - Adjusted EBITDA was $86.4 million, a 1.4% year-over-year increase, but the adjusted EBITDA margin decreased 120 bps year-over-year to 22.7%[12, 32] - Adjusted net income per diluted share increased by 6.3% year-over-year to $0.34[12, 32] - Free cash flow was $55.7 million[12] Financial Performance - Year-to-Date (YTD) Q3 Fiscal 2025 - Net sales reached $1,048.9 million, an 8.5% year-over-year increase[12] - Adjusted EBITDA was $234.4 million, a 10.5% year-over-year increase[12] - Adjusted net income per diluted share increased by 25.7% year-over-year to $0.93[12] - Free cash flow was $103.0 million[12] Fiscal Year 2025 Outlook - The company expects consolidated net sales between $1,405 million and $1,415 million, representing a 6.9% to 7.6% year-over-year growth[47, 48] - The company expects adjusted EBITDA between $318 million and $322 million, representing an 11.7% to 13.1% year-over-year growth[47, 48]

Q2 2025 Financial Performance - Revenue reached $250.7 million[3], a decrease of 3% year-over-year compared to $257.6 million in Q2 2024[14] - Adjusted EBITDA was $31.5 million[3], down 20% from $39.4 million in Q2 2024[14] - Adjusted EPS was $0.30[3], a 42% decrease compared to $0.52 in Q2 2024[14] - Gross margin was 37.3%[14], consistent with Q2 2024 but down from 39.4% in Q1 2025[14] Business Highlights - The company shipped $10 million of the $15 million in orders impacted by tariffs[3] - The company bought back $30 million of shares[3] - Sales in North America improved sequentially, driven by higher revenue in cutting, cleaning, medical, and advanced applications[13] - Sales in Asia increased due to growth in welding, cutting, and advanced applications[13] Q3 2025 Outlook - Revenue is projected to be between $225 million and $255 million[18] - Adjusted gross margin is expected to be between 36% and 38%[18] - Adjusted EPS is forecasted to be between $0.05 and $0.35[18] - Adjusted EBITDA is expected to be between $22 million and $36 million[18]

Financial Performance & Guidance - NJR raises the lower end of its fiscal year 2025 NFEPS guidance by $0.05, setting a new range of $3.20 to $3.30[5, 14] - The guidance range is above the 7%-9% long-term projected NFEPS growth[14] - Approximately 65% of fiscal year 2025 NFEPS is expected from utility operations[17] Capital Investments & Growth - NJNG's SAVEGREEN CAPEX is projected to grow over 30% to $90 million - $95 million in fiscal year 2025[24] - NJNG is authorized to invest $385.6 million in SAVEGREEN over a 30-month period ending June 30, 2027[24] - NJNG's year-to-date fiscal year 2025 capital expenditures total approximately $383 million, with about 47% earning a near real-time return[28] Clean Energy Ventures (CEV) - CEV has approximately 449 MW of commercial solar capacity in service as of July 31, 2025[30] - CEV has a solar pipeline of approximately 1.0 GW of investment options for future solar growth[31] - CEV expects approximately 131 MW of solar projects to be in service over the next two years, representing over $350 million in investment[31] Business Segments Performance - For the third quarter of fiscal year 2025, NJNG's NFE was $16.2 million, while the consolidated NFE was $6.2 million[41] - For the year-to-date fiscal year 2025, NJNG's NFE was $69.1 million, while the consolidated NFE was $313.4 million[42] Customer Growth - NJNG serves approximately 588,300 customers in New Jersey[79, 83]

Financial Performance - The company reported a net loss of $366 million, or $070 per diluted share, but adjusted EBITDA of $1443 million, which included $212 million of fire extinguishment expense at Leer South[7] - Net cash provided by operating activities was $2202 million, and free cash flow was $1311 million[7] - Adjusted EBITDA increased by 17% quarter-over-quarter, rising from $1235 million in Q1 to $1443 million in Q2[14, 15] - Free cash flow increased significantly from $491 million in Q1 to $1311 million in Q2[15] Capital Allocation - The company returned $871 million to investors through share repurchases and dividends in Q2, bringing the year-to-date total to $1937 million[7] - $819 million was invested to repurchase 12 million shares, representing approximately 2% of shares outstanding, at an average price of $6964 per share during Q2[21] - Year-to-date, $1832 million has been invested to repurchase 26 million shares, or about 5% of shares outstanding[21] - As of June 30, 2025, $8168 million remained authorized under the $1 billion share repurchase program[21] Operational Highlights - The company is targeting annual cost savings and operating synergies between $150 million and $170 million following the merger[7, 22] - Powder River Basin segment achieved sales volumes of 126 million tons[16] - High calorific value thermal segment cash cost of coal sold decreased by 8% quarter-over-quarter, from $4278 to $3947 per ton[30]

Financial & Operational Highlights - Atlas Energy Solutions reported Q2'25 Revenue of $289 million[16] - The company's Q2'25 Adjusted EBITDA was $71 million[16] - Net Cash from Operating Activities for Q2'25 reached $89 million[16] - Q2'25 Adjusted Free Cash Flow was $49 million[16] - The company returned $314 million to shareholders since inception[16] - $229 million has been returned to shareholders since IPO[16] Market Position & Logistics - Atlas Energy Solutions is the largest Permian Basin Frac Sand Provider[21] - The company directs over 80% of its volumes to large-cap companies (defined as $10B+ market capitalization)[21] - The Dune Express is expected to reduce trucking miles by approximately 60-70%[33] - Atlas deliveries are expected to reduce emissions by approximately 60 to 70% relative to traditional deliveries[37] Distributed Power Solutions - The company has a generator fleet of over 900 natural-gas powered units, generating over 225 MW of power[25] - In-house remanufacturing costs are approximately 50%+ lower than third-party costs, providing a competitive advantage[27] Market Data - The company's market capitalization is $1.5 billion and enterprise value is $2.0 billion as of August 1, 2025[11]

Financial Performance - Adjusted EBITDA for Q2 2025 reached $1808 million, an 8% increase compared to $1667 million in Q2 2024[7] - Adjusted Earnings per Share increased by 7% from $043 in Q2 2024 to $046 in Q2 2025[21] - Available Funds From Operations increased by 5% from $1250 million to $1317 million[21] - The company increased Adjusted EBITDA guidance by $50 million, now targeting $775 billion at the midpoint[3] - The company anticipates 9% CAGR Adjusted EBITDA growth from 2020 to 2025G, reaching $76 - $79 billion[12] Strategic Initiatives & Growth Projects - Williams completed 6 projects recently, enhancing transmission and earnings in the Gulf and West regions[3] - A precedent agreement was signed for Transco's Northeast Supply Enhancement[3] - Williams acquired Saber Midstream in the Haynesville, expanding its footprint[3] - The company's 2025 Adjusted EBITDA guidance has increased cumulatively by $350 million since the original issuance[14] Sustainability - The 2024 Sustainability Report was published, highlighting industry-leading performance[4] - The company is targeting a 30% reduction in carbon intensity from 2018 levels by 2028[101]

SECOND QUARTER 2025 Earnings Conference Call August 5, 2025 M P L X | 2 Q 2 0 2 5 FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements regarding MPLX LP (MPLX). These forward-looking statements may relate to, among other things, MPLX's expectations, estimates and projections concerning its business and operations, financial priorities, including with respect to positive free cash flow and distribution coverage, strategic plans, capital return plans, capital expenditure plans, ope ...

Investor Relations Pricing Theory 2025 Q 2 and Practice 1 • our ability to underwrite and price risks accurately and to charge adequate rates to policyholders; • our ability to establish accurate loss reserves; • the impact of severe weather, other catastrophe events and climate change; • the effectiveness of our reinsurance programs and the continued availability of reinsurance and performance by reinsurers; • the secure and uninterrupted operation of the systems, facilities and business functions and the ...

Financial Performance - Q2 2025 - Net operating revenue increased by 12.0% to $1,457.7 million compared to $1,301.2 million in Q2 2024[8] - Adjusted EBITDA increased by 17.2% to $318.6 million compared to $271.8 million in Q2 2024[8] - Adjusted EPS increased by 26.1% to $1.40 compared to $1.11 in Q2 2024[8] - Adjusted free cash flow increased by 30.5% to $185.9 million compared to $142.5 million in Q2 2024[8] Financial Performance - YTD Q2 2025 - Net operating revenue increased by 11.3% to $2,913.1 million compared to $2,617.2 million in YTD Q2 2024[8] - Adjusted EBITDA increased by 16.0% to $632.2 million compared to $544.8 million in YTD Q2 2024[8] - Adjusted EPS increased by 24.2% to $2.77 compared to $2.23 in YTD Q2 2024[8] - Adjusted free cash flow increased by 31.7% to $408.3 million compared to $310.1 million in YTD Q2 2024[8] Revenue Details - Inpatient revenue increased by 11.7% to $1,413.7 million in Q2 2025 compared to $1,265.5 million in Q2 2024[13] - Outpatient and other revenue increased by 23.2% to $44.0 million in Q2 2025 compared to $35.7 million in Q2 2024, including an $8.5 million increase in Medicaid supplemental payments[13] - Discharges increased by 7.2% to 65,237 in Q2 2025 compared to 60,833 in Q2 2024[13] 2025 Guidance (Updated) - Net Operating Revenue guidance increased to $5,880 to $5,980 million from the previous guidance of $5,850 to $5,925 million[22] - Adjusted EBITDA guidance increased to $1,220 to $1,250 million from the previous guidance of $1,185 to $1,220 million[22] - Adjusted earnings per share guidance increased to $5.12 to $5.34 from the previous guidance of $4.85 to $5.10[22]

Financial Performance - Q2 2025 - Net sales reached $175 million, a 2% organic growth compared to $172 million in Q2 2024[17] - Adjusted EBITDA was $17 million, representing a 10% margin, compared to $27 million in Q2 2024[17] - Adjusted EPS was $0.17, compared to $0.34 in Q2 2024[17] Segment Performance - Specialty Nutrition Systems net sales grew to $103 million, a 5% organic growth, compared to $98 million in Q2 2024[20] - Specialty Nutrition Systems operating profit was $18 million, representing an 18% margin, compared to $22 million in Q2 2024[21] - Pain Management & Recovery net sales grew to $61 million, a 34% organic growth, compared to $59 million in Q2 2024[26] - Pain Management & Recovery operating profit increased to $2 million, compared to $0 million in Q2 2024[27] Financial Position - Cash decreased to $90 million as of June 30, 2025, compared to $108 million as of December 31, 2024[30] - Net debt decreased to $15 million as of June 30, 2025, compared to $27 million as of December 31, 2024[30] - Net Debt / EBITDA ratio was approximately 02x as of June 30, 2025, compared to approximately 03x as of December 31, 2024[30] 2025 Outlook - Sales guidance reaffirmed at $665 million to $685 million[33] - Adjusted diluted EPS estimate maintained at $075 to $095[33]